SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-089592
Filing Date
2024-08-02
Accepted
2024-08-02 07:38:25
Documents
85
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-20240630.htm   iXBRL 10-Q 2684460
2 EX-31.1 flgt-ex31_1.htm EX-31.1 14416
3 EX-31.2 flgt-ex31_2.htm EX-31.2 14523
4 EX-32.1 flgt-ex32_1.htm EX-32.1 16406
  Complete submission text file 0000950170-24-089592.txt   12179234

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT flgt-20240630.xsd EX-101.SCH 1393033
88 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20240630_htm.xml XML 2785841
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 241168887
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)